Risk of Type 2 Diabetes: Insulin resistance is a major precursor to the development of type 2 diabetes
Doubling doses is not recommended
Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24.11 (NEP 24.11) and renal clearance, resulting in a half-life of approximately 2 minutes
Semaglutide is substantially superior to exenatide in weight loss efficacy (14.9% vs 2-4%), glycemic control (SUSTAIN 3 head-to-head), cardiovascular outcomes (proven superiority vs non-inferiority only), and dosing convenience (pre-filled weekly pen vs reconstitution)
For example, alcohol metabolites can promote enzyme synthesis and activate proteases, leading to local autodigestion of pancreatic tissue
The primary outcome (the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke) was less frequent in the liraglutide group (13.0% vs